share_log

Piper Sandler Initiates Coverage On Boundless Bio With Overweight Rating, Announces Price Target of $20

Benzinga ·  Apr 22 17:20

Piper Sandler analyst Joseph Catanzaro initiates coverage on Boundless Bio (NASDAQ:BOLD) with a Overweight rating and announces Price Target of $20.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment